These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7884926)

  • 21. Construction and characterization of two infectious molecular clones of encephalomyocarditis virus.
    Naviaux RK; Cohen SH; Vanden Brink KM; Jordan GW
    J Virol; 1990 Feb; 64(2):913-7. PubMed ID: 2153252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice.
    Rieder E; Bunch T; Brown F; Mason PW
    J Virol; 1993 Sep; 67(9):5139-45. PubMed ID: 8394441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
    Ruiz AJ; Hadac EM; Nace RA; Russell SJ
    J Virol; 2016 Apr; 90(8):4078-4092. PubMed ID: 26865716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Virulence comparison of genetic engineering virus containing different length poly(C) tract of foot-and-mouth disease virus].
    Bai X; Li P; Sun P; Li Y; Bao H; Lu Z; Cao Y; Guo J; Liu Z
    Wei Sheng Wu Xue Bao; 2008 Dec; 48(12):1654-8. PubMed ID: 19274849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The encephalomyocarditis virus.
    Carocci M; Bakkali-Kassimi L
    Virulence; 2012 Jul; 3(4):351-67. PubMed ID: 22722247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variability of encephalomyocarditis virus (EMCV) isolates.
    Denis P; Liebig HD; Nowotny N; Billinis C; Papadopoulos O; O'Hara RS; Knowles NJ; Koenen F
    Vet Microbiol; 2006 Mar; 113(1-2):1-12. PubMed ID: 16406410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of encephalomyocarditis virus in a cell-free system: from DNA to RNA virus in one tube.
    Kobayashi T; Nakamura Y; Mikami S; Masutani M; Machida K; Imataka H
    Biotechnol Lett; 2012 Jan; 34(1):67-73. PubMed ID: 21952914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cell extract-derived cell-free systems for virus synthesis.
    Kobayashi T; Machida K; Imataka H
    Methods Mol Biol; 2014; 1118():149-56. PubMed ID: 24395414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The poly(C) region affects progression of encephalomyocarditis virus infection in Langerhans' islets but not in the myocardium.
    Zimmermann A; Botta A; Arnold G; Eggers HJ; Nelsen-Salz B
    J Virol; 1997 May; 71(5):4145-9. PubMed ID: 9094698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of encephalomyocarditis virus pathogenicity due to a mutation at position 100 of VP1.
    Zhu S; Ge X; Gong X; Guo X; Chen Y; Yang H
    Sci China Life Sci; 2011 Jun; 54(6):535-43. PubMed ID: 21706414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of the capsid coding region of a virulent encephalomyocarditis virus isolate after serial cell passages and assessment of its virulence.
    Denis P; Koenen F
    Arch Virol; 2003 May; 148(5):903-12. PubMed ID: 12721798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential IFN-alpha/beta production suppressing capacities of the leader proteins of mengovirus and foot-and-mouth disease virus.
    Hato SV; Sorgeloos F; Ricour C; Zoll J; Melchers WJ; Michiels T; van Kuppeveld FJ
    Cell Microbiol; 2010 Mar; 12(3):310-7. PubMed ID: 19863558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage site mutations in the encephalomyocarditis virus P3 region lethally abrogate the normal processing cascade.
    Hall DJ; Palmenberg AC
    J Virol; 1996 Sep; 70(9):5954-61. PubMed ID: 8709217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heterogeneity of the poly(C) tract of encephalomyocarditis virus RNA].
    Svitkin IuV; Krupp G; Gross HJ
    Bioorg Khim; 1983 Dec; 9(12):1638-43. PubMed ID: 6091690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of endogenous viral polymerase, 3D(pol), in preparations of Mengo and encephalomyocarditis viruses.
    Frolov VG; Duque H; Palmenberg AC
    Virology; 1999 Jul; 260(1):148-55. PubMed ID: 10405366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of interferon in the protection of ICR Swiss male mice by the nondiabetogenic variant of encephalomyocarditis virus against virus-induced diabetes mellitus.
    Kaptur PE; Thomas DC; Giron DJ
    J Interferon Res; 1989 Dec; 9(6):671-8. PubMed ID: 2481700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and genetic characterization of encephalomyocarditis virus 1 from a deceased captive hamadryas baboon.
    Vyshemirskii OI; Agumava AA; Kalaydzyan AA; Leontyuk AV; Kuhn JH; Shchetinin AM; Vishnevskaya TV; Eremyan AA; Alkhovsky SV
    Virus Res; 2018 Jan; 244():164-172. PubMed ID: 29113825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. System of double infection between vaccinia virus and mengovirus.
    Freda CE; Buck CA
    J Virol; 1971 Sep; 8(3):293-302. PubMed ID: 4330362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. the influence of the host cell on the inhibition of virus protein synthesis in cells double infected with vesicular stomatitis virus and mengovirus.
    Otto MJ; Lucas-Lenard J
    J Gen Virol; 1980 Oct; 50(2):293-307. PubMed ID: 6257824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translation of capped virus mRNA in encephalomyocarditis virus-infected cells.
    Alonso MA; Carrasco L
    J Gen Virol; 1982 Jun; 60(Pt 2):315-25. PubMed ID: 6286854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.